Şen, S. Et Al. 2025. Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD). Journal of Neuroimmunology , vol.407 .

Şen, S., KÜRTÜNCÜ, M., Demir, S., GÜNDÜZ, T., Demirel, E., Tütüncü, M., ... Uzunköprü, C.(2025). Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD). Journal of Neuroimmunology , vol.407.

Şen, Sedat Et Al. "Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD)," Journal of Neuroimmunology , vol.407, 2025

Şen, Sedat Et Al. "Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD)." Journal of Neuroimmunology , vol.407, 2025

Şen, S. Et Al. (2025) . "Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD)." Journal of Neuroimmunology , vol.407.

@article{article, author={Sedat Şen Et Al. }, title={Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD)}, journal={Journal of Neuroimmunology}, year=2025}